THIS WEBSITE IS PART OF THE ROUTES GAME EXPERIENCE
At Prometha we are proud of the success and global reach of our pharmaceutical products.
In 2008 we brought six new products to market, each designed to improve quality of life for sufferers of a variety of conditions. Our two most recent launches:
An in vitro diagnostic test for the risk assessment of contracting bladder cancer.
A pre-natal test for the Xp21 gene that will indicate whether a child is likely to develop Duchenne muscular dystrophy.